Cero Therapeutics Holdings, Inc.
CEROW- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001870404
No open-market purchases or sales by Cero Therapeutics Holdings, Inc. insiders were filed in the last 90 days; 1 institution reported holding it in 13F filings for Q2 2026, worth $4 in total; no superinvestor holds it.
Other share classesCERO
Q1 2022 vs. Q4 2021
How the institutions holding Cero Therapeutics Holdings, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 31 | 36 | +5 |
| Shares | 3.28M | 4.67M | +1.39M (+42.3%) |
| Value | $1.35M | $1.02M | −$330.0K (−24.5%) |
New holders (8)
Institutions that held Cero Therapeutics Holdings, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Periscope Capital Inc. | 299,800 | $65.0K | 0.00% |
| Linden Advisors LP | 249,999 | $55.0K | 0.00% |
| Context Capital Management, LLC | 200,000 | $44.0K | 0.00% |
| Parallax Volatility Advisers, L.P. | 115,296 | $25.0K | 0.00% |
| Picton Mahoney Asset Management | 75,000 | $17.0K | 0.00% |
| Bulldog Investors, LLP | 54,745 | $11.0K | 0.00% |
| HGC Investment Management Inc. | 50,000 | $11.0K | 0.00% |
| Ancora Advisors, LLC | 2,500 | $1.00K | 0.00% |
Sold out (3)
Institutions that held Cero Therapeutics Holdings, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| D. E. Shaw & Co., Inc. | 25,000 | $11.0K |
| Ramius Advisors LLC | 10,000 | $4.00K |
| Clear Street LLC | 5,797 | $2.00K |